LIVINGLIVING
COMPANY PROFILE
NEMAURA MEDICAL
N
emaura Medical's
sugarBEAT® sensor is
soon to be available to
purchase on-line in the
UK. Bucking the trend
for sensors aimed at people on insulin, the
company's intention is to focus on people
with Type 2 diabetes (though obviously
not disallowing anyone with Type 1 to use
their sensor if they should so wish).
Faz Chowdhury, CEO of the company,
has been working on this project since
2011. He's clear about the focus of the
product and the company, saying: "Our
mission is to help people with Type 2 to
reverse their diabetes. Even if someone
with Type 2 diabetes does not reverse their
diagnosis, they should be able to greatly
improve their control and outcomes. We
can show that the device not only enables
this but can even stop people with prediabetes becoming diagnosed with it, if
intervention comes in time."
This type of intervention is called
either 'preventative medicine' or 'early
diagnostics'. He see a future when
HbA1c is simply a diagnostic test when
people are first diagnosed, and then users
would immediately move to sugarBEAT
intermittent daily testing, because
it's a more powerful tool for users to
understandi lifestyle choices (food,
activity, meds). In addition, indications of
time spent 'in range' (TIR) produced by
Faz Chowdhury,
CEO Nemaura Medical
CGM technology is alreaady considered
as being a more informative tool than an
HbA1c test. The plan is to offer lifestyle
education alongside use of the sensor
in order to get the best outcomes.
The offering is called BEAT®diabetes
technology, which is a platform, while
sugarBEAT is the device within the
offering that measures glucose.
Our mission is to help
people with Type
2 to reverse their
diabetes. Even if they
do not reverse their
diagnosis, they should
be able to greatly
improve their control
and outcomes. -
Nemaura Medical
CEO Faz Chowdhury
"